INTERNATIONAL PATENT: FUNDACION PÚBLICA GALEGA INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA FILES APPLICATION FOR "IN VITRO METHOD FOR PREDICTING THE RESPONSE OF PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS TO A TREATMENT WITH TUMOR NECROSIS FACTOR (TNF) INHIBITORS"

GENEVA, Sept. 29 -- FUNDACION PÚBLICA GALEGA INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA (Travesia da Choupana, s/n, Hospital Clinico Universitario de Santiago de Compostela, Edificio D, 1ª planta15706 Santiago de Compostela) filed a patent application (PCT/EP2025/057813) for " IN VITRO METHOD FOR PREDICTING THE RESPONSE OF PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS TO A TREATMENT WITH TUMOR NECROSIS FACTOR (TNF) INHIBITORS" on Mar 21, 2025. With publication no. WO/2025/196275, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property...